Immunomodulating Agents

Home > API Products > Immunomodulating Agents
Baricitinib

Baricitinib

  • Category Rheumatoid Arthritis
  • CAS 1187594-09-7
  • Specification In-house
  • US DMF 36030
  • CEP / Other DMF N/A
  • GMP certification TFDA
  • Inspection TFDA
  • StatusCompleted process development
  • Major Market USA, EU and Japan Market